Verónica
Briz
Publicacións nas que colabora con Verónica Briz (12)
2009
-
Raltegravir and etravirine are active against HIV Type 1 group O
AIDS Research and Human Retroviruses, Vol. 25, Núm. 2, pp. 225-227
2008
-
Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years
AIDS, Vol. 22, Núm. 11, pp. 1371-1374
-
Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years
Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 2, pp. 405-410
2007
-
Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use
AIDS, Vol. 21, Núm. 11, pp. 1487-1490
-
Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy
Journal of Medical Virology, Vol. 79, Núm. 8, pp. 1040-1046
-
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 4, pp. 885-888
-
Short communication: Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy
AIDS Research and Human Retroviruses, Vol. 23, Núm. 9, pp. 1078-1082
2006
-
Entrada del virus de la inmunodeficiencia humana en las células: Mecanismos y posibilidades terapéuticas
Medicina Clinica, Vol. 126, Núm. 9, pp. 341-348
-
HIV entry inhibitors: Mechanisms of action and resistance pathways
Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 4, pp. 619-627
-
HIV tropism: Diagnostic tools and implications for disease progression and treatment with entry inhibitors
AIDS, Vol. 20, Núm. 10, pp. 1359-1367
-
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors
AIDS, Vol. 20, Núm. 11, pp. 1558-1560
2005
-
Enfuvirtide, the first fusion inhibitor to treat HIV infection
AIDS Reviews, Vol. 7, Núm. 3, pp. 139-147